Tisdag 9 Juni | 02:50:49 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-11-05 07:30 Kvartalsrapport 2026-Q3
2026-07-17 07:30 Kvartalsrapport 2026-Q2
2026-05-27 - X-dag ordinarie utdelning APOTEA 0.60 SEK
2026-05-26 - Årsstämma
2026-04-29 - Kvartalsrapport 2026-Q1
2026-02-04 - Bokslutskommuniké 2025
2025-11-06 - Kvartalsrapport 2025-Q3
2025-07-18 - Kvartalsrapport 2025-Q2
2025-05-30 - X-dag ordinarie utdelning APOTEA 0.00 SEK
2025-05-28 - Årsstämma
2025-05-08 - Kvartalsrapport 2025-Q1
2025-02-06 - Bokslutskommuniké 2024

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-06-01 16:05:00

Apotea, Sweden's largest online pharmacy, is strengthening its Board of Directors through the election of Johan Lundgren and Eva Nilsagård as new members at the Annual General Meeting.

Eva Nilsagård has over 30 years of experience in leading positions within finance and business development, in both large international groups and entrepreneurial companies. She has extensive experience with organizational changes and several initial public offerings (IPOs), including listings on Nasdaq's main market. She has broad expertise in financial management, change management, and publicly listed companies, and currently holds several board assignments with a focus on auditing and governance.

"It is a great honor to join Apotea's board. Apotea is an impressive Swedish success story with strong growth and a clear focus on sustainability. I look forward to contributing my experience in financial management and corporate development during the next phase of the company's journey," says Eva Nilsagård.

Johan Lundgren has worked within the H&M Group since 2008 and has held leading roles in sales, business development, and operations, both globally and locally. After a period as Chief Operating Officer at Fortnox, he returned to H&M in 2024 and is currently responsible for strategy and innovation in the role of Chief Strategy and Innovation Officer.

"Apotea has impressed me for a long time with its strong customer focus, its innovative power, and its clear social responsibility. The company is on a very exciting journey, and I look forward to contributing to its continued development together with the board and the management," says Johan Lundgren.

These recruitments reflect Apotea's continued focus on long-term growth, innovation, and strong corporate governance.

"We are very pleased to welcome Eva and Johan to Apotea's board. They bring important experience and strengthen the board ahead of Apotea's continued growth," says Cecilia Qvist, Chair of the Board at Apotea.

"Eva and Johan complement the business very well with their expertise in finance, strategy, and business development. We look forward to working together going forward," says Pär Svärdson, CEO of Apotea.